Indo US Bio-Tech Ltd. Hits Upper Circuit for the 2nd Straight Session on BSE, 28 October 2026

Agri stocks rarely get a clean read from a single session, and Indo US Bio-Tech Ltd. (INDOUS) is no exception. The Indo US Bio-Tech upper circuit streak reached 2 sessions on BSE on 28 October 2026, as the stock was held at Rs 86.42, up 19.99% from the previous close of Rs 72.02.

The market cap stood at Rs 144.41 crore at that level, which keeps it a small counter in the Agriculture space. The stock sat at its band price when this was written.

Key Takeaways

• Indo US Bio-Tech Ltd. (INDOUS) hit the upper circuit on BSE at Rs 86.42 on 28 October 2026.
• The session move was +19.99% against a previous close of Rs 72.02.
• Market capitalisation stood at Rs 144.41 crore with a PE ratio of 12.61.
• This is the 2nd straight session at the upper circuit, with the run starting on 27 October 2026.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	Indo US Bio-Tech Ltd.
Current Price / LTP	Rs 86.42
Day Move	19.99%
Previous Close	Rs 72.02
Day Open	Rs 83.97
Day High	Rs 86.42
Day Low	Rs 82
Upper Circuit Price	Rs 86.42
Upper Circuit Limit	Rs 86.42
Market Cap	Rs 144.41 crore
Selected Exchange	BSE
PE Ratio	12.61

All figures above are as of 28 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

The session began at Rs 83.97 on BSE, against a previous close of Rs 72.02. Over the day the price moved within Rs 82 and Rs 86.42, and the top of that range matched the band price of Rs 86.42.

That works out to a gain of Rs 14.4 on the day, or 19.99%. All figures here come from BSE alone, which keeps the numbers comparable with one another, since price bands and previous-close values can differ between exchanges.

The band limit for the session was Rs 86.42, and the stock reached exactly that level.

The Indo US Bio-Tech Upper Circuit Streak So Far

This is session 2 of an unbroken run for Indo US Bio-Tech Ltd. The streak began on 27 October 2026, from a base price of Rs 60.31. Across the run the stock has moved 43.29% in total.

A repeated upper circuit matters more than a single one. It says the order book has stayed one-sided across multiple sessions rather than reacting to a single day of news, and for anyone holding the stock it means the price on screen has been hard to trade at for several days running.

This page is the running record for the streak and is updated each session rather than being replaced by a fresh article. That keeps one address for the event instead of splitting the same story across competing pages.

Why Indo US Bio-Tech Ltd. Hit Upper Circuit

Buying interest took the stock up to its exchange-defined price band, and that is the only mechanism visible in the data. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move is best read through price action and market sentiment.

With no confirmed trigger on record, the article does not tie the move to earnings, a corporate action, sector news or market rumours. A later confirmed announcement, if one appears, would belong in a separate update.

The stock reached the upper circuit level of Rs 86.42 within the session.

What the Indo US Bio-Tech Upper Circuit Means

Under an exchange price band, an upper circuit marks the highest level a stock can touch in one trading session. For Indo US Bio-Tech Ltd., that captured level was Rs 86.42 on 28 October 2026.

Bands exist to dampen sharp swings and keep trading orderly. They describe market structure and say nothing about future returns. Here, the circuit simply records what happened in the session and where the band was reached.

Indo US Bio-Tech Ltd. Fundamentals and Valuation

Market data adds context that price action alone cannot. Indo US Bio-Tech Ltd. showed a PE ratio of 12.61 and a PB ratio of 1.51, with a book value of Rs 47.66 and EPS of 5.71, on a market cap of Rs 144.41 crore. The sector is listed as Agri and the industry as Agriculture. These are descriptive indicators, not a buy, sell or hold view.

A PB ratio of 1.51 means the market priced the company above its book value per share. A premium like that can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For anyone tracking upper circuit moves, such metrics help separate the price event from the wider financial profile. A sharp one-day jump draws attention, yet valuation and return ratios still call for separate review.

Peer and Sector Context

Indo US Bio-Tech Ltd. belongs to the Agriculture industry within the Agri sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
Venky'S (India) Ltd.	Rs 2273.13 crore	13.11	1.38	9.07%
AVT Natural Products Ltd.	Rs 1376.04 crore	16.42	2.33	12.16%
REGAAL RESOURCES LIMITED	Rs 911.19 crore	15.23	1.83	15.26%
Bombay Super Hybrid Seeds Ltd.	Rs 870.66 crore	30.22	5.88	22.62%
Freshara Agro Exports Ltd.	Rs 853.22 crore	22.75	5.13	22.67%

Several of these peers are far larger by market capitalisation than Indo US Bio-Tech Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Indo US Bio-Tech Ltd.'s PE ratio was 12.61, compared with an available peer PE average of 19.55, calculated from the 5 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 31.38, the 50-day moving average was 73.65 and the 200-day moving average was 85.99.

Worth flagging: the RSI reading sits on the opposite side of neutral to the day move. Indicator values in the dataset can lag the live session, so they should be checked against a live chart before being relied on.

What Readers Should Know

The one firmly confirmed fact is that Indo US Bio-Tech Ltd. hit the upper circuit on BSE at Rs 86.42 on 28 October 2026, a day move of 19.99%.

Execution is the practical catch after a session like this. Buyers queue at the band while sellers step back, so the quoted price may not be one at which a trade can actually be done. The second caveat is that no official catalyst was confirmed at the time of writing.

Upper circuit events work best as market updates rather than stand-alone investment conclusions. The band points to strong near-term interest, but any follow-up should weigh business fundamentals, valuation, liquidity, risk and confirmed company disclosures.

Frequently Asked Questions

Why did Indo US Bio-Tech Ltd. hit upper circuit on 28 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

How many sessions has Indo US Bio-Tech Ltd. hit upper circuit in a row?

This is session 2 of the current run, which began on 27 October 2026. This page is updated each session rather than replaced with a new article.

What was INDOUS share price on 28 October 2026?

The last traded price used in this article was Rs 86.42 on BSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for INDOUS?

The upper circuit price was Rs 86.42. The stated exchange upper circuit limit was Rs 86.42. The event numbers in this article are aligned to BSE.

What is Indo US Bio-Tech Ltd.'s market cap and PE ratio?

Indo US Bio-Tech Ltd.'s market cap was Rs 144.41 crore. PE ratio was 12.61.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting an upper circuit mean Indo US Bio-Tech Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Indo US Bio-Tech Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Indo US Bio-Tech Ltd. the stated limit was Rs 86.42. For this session, Indo US Bio-Tech Ltd. moved 19.99%.